The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer
Open accessAbstract
Nonresolving inflammation in the intestine predisposes individuals to the development of colitis-associated cancer (CAC). Inflammasomes are thought to mediate intestinal homeostasis, and their dysregulation contributes to inflammatory bowel diseases and CAC. However, few agents have been reported to reduce CAC by targeting inflammasomes. Here we show that the small molecule andrographolide (Andro) protects mice against azoxymethane/dextran sulfate sodium-induced colon carcinogenesis through inhibiting the NLRP3 inflammasome. Administration of Andro significantly attenuated colitis progression and tumor burden. Andro also inhibited NLRP3 inflammasome activation in macrophages both in vivo and in vitro, as indicated by reduced expression of cleaved CASP1, disruption of NLRP3-PYCARD-CASP1 complex assembly, and lower IL1B secretion. Importantly, Andro was found to trigger mitophagy in macrophages, leading to a reversed mitochondrial membrane potential collapse, which in turn inactivated the NLRP3 inflammasome. Moreover, downregulation of the PIK3CA-AKT1-MTOR-RPS6KB1 pathway accounted for Andro-induced autophagy. Finally, Andro-driven inhibition of the NLRP3 inflammasome and amelioration of murine models for colitis and CAC were significantly blocked by BECN1 knockdown, or by various autophagy inhibitors. Taken together, our findings demonstrate that mitophagy-mediated NLRP3 inflammasome inhibition by Andro is responsible for the prevention of CAC. Our data may help guide decisions regarding the use of Andro in patients with inflammatory bowel diseases, which ultimately reduces the risk of CAC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049
Ford Alexander, C., Paul, M., Hanauer Steven, B., 谭蓓, & Dong, W. Z. (2001) · Cited by 3,021
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,890
Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis
Shimada, K., Crother, T. R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., Ramanujan, V. K., Wolf, A. J., Vergnes, L., Ojcius, D. M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.009 · Cited by 2,282
Nathan, C., & Ding, A. (2010) · Cell · doi:10.1016/j.cell.2010.02.029 · Cited by 2,183
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
Molecular Genetics of Colorectal Cancer
Fearon, E. R. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130235 · Cited by 1,805
Chemically induced mouse models of intestinal inflammation
Wirtz, S., Neufert, C., Weigmann, B., & Neurath, M. F. (2007) · Nature Protocols · doi:10.1038/nprot.2007.41 · Cited by 1,567
Cancer risk in patients with inflammatory bowel disease: A population-based study
Bernstein, C. N., Blanchard, J. F., Kliewer, E., & Wajda, A. (2001) · Cancer · doi:10.1002/1097-0142(20010215)91:4<854::aid-cncr1073>3.0.co;2-z · Cited by 1,165
Mitophagy: mechanisms, pathophysiological roles, and analysis
Ding, W.-X., & Yin, X.-M. (2012) · bchm · doi:10.1515/hsz-2012-0119 · Cited by 1,032
Sutton, C., Brereton, C., Keogh, B., Mills, K. H. G., & Lavelle, E. C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060285 · Cited by 1,010
Zaki, M. H., Boyd, K. L., Vogel, P., Kastan, M. B., Lamkanfi, M., & Kanneganti, T.-D. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.003 · Cited by 989
Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome
Bauer, C., Duewell, P., Mayer, C., Lehr, H. A., Fitzgerald, K. A., Dauer, M., Tschopp, J., Endres, S., Latz, E., & Schnurr, M. (2010) · Gut · doi:10.1136/gut.2009.197822 · Cited by 906
Weir, H. K. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg040 · Cited by 867
REINECKER, H.-C., STEFFEN, M., WITTHOEFT, T., PFLUEGER, I., SCHREIBER, S., MacDERMOTT, R. P., & RAEDLER, A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05997.x · Cited by 856
Allen, I. C., TeKippe, E. M., Woodford, R.-M. T., Uronis, J. M., Holl, E. K., Rogers, A. B., Herfarth, H. H., Jobin, C., & Ting, J. P.-Y. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100050 · Cited by 826
The inflammasome: an integrated view
Gross, O., Thomas, C. J., Guarda, G., & Tschopp, J. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01046.x · Cited by 778
Coccia, M., Harrison, O. J., Schiering, C., Asquith, M. J., Becher, B., Powrie, F., & Maloy, K. J. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111453 · Cited by 580
IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation
Ben-Sasson, S. Z., Hu-Li, J., Quiel, J., Cauchetaux, S., Ratner, M., Shapira, I., Dinarello, C. A., & Paul, W. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902745106 · Cited by 568
Inflammation and colorectal cancer: colitis-associated neoplasia
Grivennikov, S. I. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-012-0352-6 · Cited by 551
Triantafillidis, J. K., Nasioulas, G., & Kosmidis, P. (2009) · PubMed · Cited by 425
IL-1β-converting enzyme (caspase-1) in intestinal inflammation
Siegmund, B., Lehr, H.-A., Fantuzzi, G., & Dinarello, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231473998 · Cited by 421
Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease.
Ligumsky, M., Simon, P. L., Karmeli, F., & Rachmilewitz, D. (1990) · Gut · doi:10.1136/gut.31.6.686 · Cited by 400
Lupfer, C., Thomas, P. G., Anand, P. K., Vogel, P., Milasta, S., Martinez, J., Huang, G., Green, M., Kundu, M., Chi, H., et al. (2013) · Nature Immunology · doi:10.1038/ni.2563 · Cited by 384
Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata
Rajagopal, S., Kumar, R. A., Deevi, D. S., Satyanarayana, C., & Rajagopalan, R. (2003) · Journal of Experimental Therapeutics and Oncology · doi:10.1046/j.1359-4117.2003.01090.x · Cited by 318
Siegmund, B., Fantuzzi, G., Rieder, F., Gamboni-Robertson, F., Lehr, H.-A., Hartmann, G., Dinarello, C. A., Endres, S., & Eigler, A. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.281.4.r1264 · Cited by 288
Sivakumar, P. V., Westrich, G. M., Kanaly, S., Garka, K., Born, T. L., Derry, J. M. J., & Viney, J. L. (2002) · Gut · doi:10.1136/gut.50.6.812 · Cited by 267
Farrell, R. J., & Peppercorn, M. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07499-8 · Cited by 236
In vitro and in vivo anti-inflammatory effects of andrographolide
Abu-Ghefreh, A. A., Canatan, H., & Ezeamuzie, C. I. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2008.12.002 · Cited by 209
McAlindon, M. E., Hawkey, C. J., & Mahida, Y. R. (1998) · Gut · doi:10.1136/gut.42.2.214 · Cited by 193
Mitochondrial control of the NLRP3 inflammasome
Kepp, O., Galluzzi, L., & Kroemer, G. (2011) · Nature Immunology · doi:10.1038/ni0311-199 · Cited by 168 · cited 2×
“The commercial ELISA kits (Dakewe, Beijing) of murine IFNG (12-2000), murine IL17A (12-2170), murine TNF (12-2720), murine IL1B (12-2012) and human IL1B (12-1012) were used to measure the cytokine levels.”
MethodGenetic and Epigenetic Events Generate Multiple Pathways in Colorectal Cancer Progression
Pancione, M., Remo, A., & Colantuoni, V. (2012) · Pathology Research International · doi:10.1155/2012/509348 · Cited by 160
Bauer, C. A., Duewell, P., Lehr, H., Endres, S., & Schnurr, M. M. (2012) · Digestive Diseases · doi:10.1159/000341681 · Cited by 155
Coll, R. C., & O'Neill, L. A. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029539 · Cited by 143
Lee, K.-C., Chang, H., Chung, Y.-H., & Lee, T.-Y. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.03.068 · Cited by 139
Neuroprotective effects of andrographolide in a rat model of permanent cerebral ischaemia
Chan, S. J., Wong, W. S. F., Wong, P. T.-H., & Bian, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00906.x · Cited by 138
NF-κB Signaling Proteins as Therapeutic Targets for Inflammatory Bowel Diseases
Jobin, C., & Sartor, R. B. (2000) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200008000-00007 · Cited by 120
Loher, F., Bauer, C. A., Landauer, N., Schmall, K., Siegmund, B., Lehr, H. A., Dauer, M., Schoenharting, M., Endres, S., & Eigler, A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.057059 · Cited by 116
Arai, Y., Takanashi, H., Kitagawa, H., & Okayasu, I. (1998) · Cytokine · doi:10.1006/cyto.1998.0355 · Cited by 115
Zhou, J., Hu, S.-E., Tan, S.-H., Cao, R., Chen, Y., Xia, D., Zhu, X., Yang, X., Ong, C. N., & Shen, H. (2012) · Autophagy · doi:10.4161/auto.18721 · Cited by 109
Guo, W., Zhang, Y., Zhang, L., Huang, B., Tao, F.-F., Chen, W., Guo, Z., Xu, Q., & Sun, Y. (2013) · Autophagy · doi:10.4161/auto.24407 · Cited by 93
Self-citationChen, W., Feng, L., Nie, H., & Zheng, X. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs264 · Cited by 87
Hsieh, C., Hsu, M., Hsiao, G., Wang, Y. H., Huang, C.-W., Chen, S. W., Jayakumar, T., Chiu, P. T., Chiu, Y. H., & Sheu, J. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.123968 · Cited by 83
Bauer, C. A., Loher, F., Dauer, M., Mayer, C., Lehr, H. A., Schönharting, M., Hallwachs, R., Endres, S., & Eigler, A. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9802-8 · Cited by 75
Malik, M. Q., Jividen, K., Padmakumar, V. C., Cataisson, C., Li, L., Lee, J., Howard, O. M. Z., & Yuspa, S. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201351109 · Cited by 62
Dangerous Liaisons: Mitochondrial DNA Meets the NLRP3 Inflammasome
Martinon, F. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.005 · Cited by 57
Inflammasome in Intestinal Inflammation and Cancer
Nunes, T., & de Souza, H. S. P. (2013) · Mediators of Inflammation · doi:10.1155/2013/654963 · Cited by 54
Evaluation of an interleukin-1 receptor antagonist in the rat acetic acid-induced colitis model
Thomas, T. K., Will, P. C., Srivastava, A., Wilson, C. L., Harbison, M. L., Little, J., Chesonis, R. S., Pignatello, M. A., Schmolze, D., Symington, J., et al. (1991) · Inflammation Research · doi:10.1007/bf01993274 · Cited by 52
Inflammatory Bowel Disease Cancer Risk, Detection and Surveillance
Rogler, G. (2012) · Digestive Diseases · doi:10.1159/000341893 · Cited by 22
Cited by
Pattern recognition receptors in health and diseases
Li, D., & Wu, M. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00687-0 · Cited by 1,787
NLRP3 inflammasome in cancer and metabolic diseases
Sharma, B. R., & Kanneganti, T.-D. (2021) · Nature Immunology · doi:10.1038/s41590-021-00886-5 · Cited by 1,097
New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD
Larabi, A., Barnich, N., & Nguyen, H. T. T. (2020) · Autophagy · doi:10.1080/15548627.2019.1635384 · Cited by 835
Blevins, H. M., Xu, Y., Biby, S., & Zhang, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.879021 · Cited by 587
Autophagy and autophagy-related proteins in the immune system
Shibutani, S. T., Saitoh, T., Nowag, H., Münz, C., & Yoshimori, T. (2015) · Nature Immunology · doi:10.1038/ni.3273 · Cited by 582
Metadata
- Authors
- Guo, W., Sun, Y., Liu, W., Wu, X., Guo, L., Cai, P., Wu, X., Wu, X., Shen, Y., Shu, Y., Gu, Y., & Xu, Q.
- Venue
- Autophagy
- Publisher
- Informa UK Limited
- Published
- 2014-04
- Volume
- 10
- Issue
- 6
- Pages
- 972-985
- ISSN
- 1554-8627 (ISSN-L)
- 1554-8635
- OpenAlex
- W2002394315
- Cited by
- 297
- References
- 56
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.